
Programs Search and Views Navigation
March 2021
- ONLINE ON-DEMAND
Psoriatic Arthritis: Therapeutic Advances and Expert Perspectives on Managing Psoriatic Arthritis
Are you confident tailoring therapies for patients with psoriatic arthritis? In this 60-minute panel discussion, four faculty experts will discuss evaluating patients for potential signs and symptoms to ensure timely and accurate diagnosis, review mechanisms and clinical data for new and emerging agents, and determine patient- and disease-specific therapeutic approaches for psoriatic arthritis. Join Drs. Menter, Mease, Merola, and Craig to learn about the latest in psoriatic arthritis management. Click on any of these links to register and start…
Find out more »April 2021
- ONLINE ON-DEMAND
Accelerating New Standards of Oncology Care Amidst the Global Pandemic: Operational, Clinical, and Interpersonal Considerations – Gather-ed
The COVID-19 pandemic has significantly affected nearly every aspect of oncological practice because of the increased risk to patients with cancer and the impact on health care resources. This has led to rapid changes in when, where, and how to provide diagnostic procedures, treatment, and follow-up care. There is an urgent need to provide cancer care professionals with guidance, training, and support as they respond to unprecedented challenges in maintaining high-quality patient care. This activity will be delivered via…
Find out more »- ONLINE ON-DEMAND
Precision Medicine in Non-Small Cell Lung Carcinoma: New Paradigms and Best Practices in Targeted Therapy
Join Dr Ross Camidge and Dr Mark Socinski as they share insights into the selection of precision therapy for NSCLC based on tumor biomarkers and driver mutations, and strategies to proactively address treatment-related adverse events. Click here to access this 30-minute activity worth 0.50 / AMA PRA Category 1 Credit(s)TM https://www.mycme.com/courses/precision-medicine-in-non-small-cell-lung-carcinoma-new-paradigms-and-best-practices-in-targeted-therapy-7664
Find out more »May 2021
- ONLINE ON-DEMAND
Best Practices for Disease Detection, Risk Stratification, and Treatment Selection in Osteoporosis
Are you confident implementing recent osteoporosis recommendations in your clinical practice? Despite clear guidance, screening rates remain suboptimal and many clinicians are hesitant to implement pharmacologic therapy. This 15-minute case-based CME activity, developed by osteoporosis experts Dr Rachel Pessah-Pollack and Dr Steven Petak, addresses screening, diagnosis, treatment strategies, and patient-specific treatment considerations for osteoporosis. https://realcme.com/learner/course/2812
Find out more »- ONLINE ON-DEMAND
Current Concepts in Diagnosing and Treating Alzheimer’s Disease
Are you confident diagnosing and treating patients with Alzheimer’s disease? This 30-minute video activity offers pearls to optimize care for patients with this challenging neurological disease. Join Dr Zoe Arvanitakis and Dr Marwan Sabbagh as these experts discuss the importance of an early and accurate diagnosis, review current agents and treatment strategies, and highlight emerging disease-modifying agents that could change the way Alzheimer’s disease is approached in the future. Expert insights from the 2021 AD/PD Conference are also addressed in…
Find out more »- ONLINE ON-DEMAND
Making a Difference in Patients with Spinal Muscular Atrophy: Improving Diagnosis and Treatment
Spinal muscular atrophy (SMA) is an inherited condition that places a tremendous burden on patients, families, caregivers, and healthcare providers, with patients experiencing a wide range of complications and symptoms that are detrimental to day-to-day life. Although SMA management has historically consisted of supportive care, the therapeutic landscape has changed dramatically following the recent approval of transformative medications, particularly disease-modifying therapies (DMTs) that improve motor function and survival. In this educational activity, experts in SMA seek to bring clinicians up-to-date…
Find out more »June 2021
- ONLINE ON-DEMAND
The Role of Telehealth in Pediatric and Adult Infections: Best Practices and Care Considerations for Influenza
Are you prepared to manage influenza in the era of COVID-19? Listen to Dr Paul G. Auwaerter’s and Dr Javeed Siddiqui’s discussion on the challenges of influenza management in the midst of the COVID-19 pandemic. Explore solutions to your questions about best practices to assess influenza via telehealth, strategies for influenza prophylaxis, and selecting antivirals for children, adolescents, and adults, including patients at high risk of influenza complications. Click here to enter this activity: https://learning.freecme.com/a/37397P2C6ABt
Find out more »- ONLINE ON-DEMAND
Rising to the Challenge: The Evolving Landscape of Maintenance Therapy in Ovarian Cancer
The landscape of maintenance treatment options for ovarian cancer has been rapidly expanding and continues to evolve as new data emerge. Maintenance therapy with poly(ADP-ribose) polymerase (PARP) inhibitors and bevacizumab has demonstrated improvements in progression-free survival. A recent trial showed that maintenance therapy involving a PARP inhibitor improved overall survival in patients with platinum-sensitive recurrent ovarian cancer associated with BRCA1/2 mutations. In this enduring activity, an expert will examine relevant advances in genetic biomarker testing to individualize therapy, assess recent efficacy and…
Find out more »- ONLINE ON-DEMAND
A Multidisciplinary Team Approach to Patient-Centric Management of Fabry Disease – Gather-ed
Patients with Fabry disease have a significantly shorter life expectancy compared to the general population, often due to cardiac or renal complications of this rare disease. There are only 2 approved therapies for Fabry disease—enzyme replacement therapy and chaperone therapy. Management of Fabry disease and its complications is a rapidly evolving field with ongoing developments, from recent guideline recommendations to new data on approved therapies to promising clinical trials on investigational therapies. Timely and proper management is essential to slow…
Find out more »July 2021
- ONLINE ON-DEMAND
The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy
In this educational activity, faculty members Nina Delaney Wagner-Johnston, MD, and Seema A. Bhat, MD, review current efficacy and safety data for targeted therapies approved for patients with treatment-naïve or relapsed/refractory (R/R) CLL, as well as emerging strategies for treatment. They evaluate clinical trial data, along with patient- and disease-related factors, that allow for the individualization of therapy selection and sequencing of therapy in first and second lines of therapy and beyond. https://reachmd.com/programs/cme/evolving-landscape-chronic-lymphocytic-leukemia-selecting-and-managing-targeted-therapy/12643/
Find out more »August 2021
- ONLINE ON-DEMAND
Strategies for PD-L1 Testing and Targeted Therapy With Immune Checkpoint Inhibitors for NSCLC
Join Dr Hossein Borghaei and Dr Kurt Schalper in this personalized adaptive learning platform as they share insights into the role of PD-L1 testing to determine the best approach to ICI therapy, current efficacy and safety data for ICI therapies in NSCLC, and how to identify and mitigate immune-related adverse events (irAEs). Click below to enter this activity: https://spirelearning.realcme.com/learner/course/2828
Find out more »- ONLINE ON-DEMAND
More Targets, More Targeted Therapies: Evolving Concepts and Therapies for Atopic Dermatitis
Are you prepared to accurately assess the severity of atopic dermatitis (AD) across a diverse spectrum of age, comorbidities, and skin of color? Are you aware of the new and emerging targeted therapy options for mild to severe AD and the evolving physiological concepts behind their rationale? The goals of this activity are to educate pediatric and adult dermatologists, allergists, and dermatologic advanced practice providers (APPs) on the diagnosis and assessment of AD and its severity in children, adolescents, and…
Find out more »October 2021
- ONLINE ON-DEMAND
A New Era in Managing Alzheimer’s Disease: Highlights From AAIC 2021
Did you miss the Alzheimer’s Association International Conference (AAIC) 2021 Annual Virtual Scientific Meeting? Key advances in the diagnosis and treatment of Alzheimer’s disease (AD) were presented at the AAIC 2021 meeting, including several reports on novel biomarkers for identifying early signs of AD and late-breaking clinical data on approved and emerging treatment strategies. Join Dr Zoe Arvanitakis and Dr Marwan Sabbagh as they share important take-home messages from select abstracts presented at the AAIC 2021 meeting, and access our resource library stocked…
Find out more »December 2021
- ONLINE ON-DEMAND
Itching for a CSU Cure: The Shift From Symptom Relief to Curative Therapies – A Caucasian Adult Female With Recurrent, Uncontrolled Angioedema and Urticaria
Join Chesahna Kindred, MD, MBA, FAAD, and Jonathan A. Bernstein, MD, as they discuss missed opportunities for the diagnosis, management, and assessment of chronic spontaneous urticaria (CSU) in this interactive learning experience that uniquely mirrors what you may encounter in clinical practice. The activity will present you with a CSU patient receiving suboptimal care and challenge your clinical decision-making skills. https://realcme.realcme.com/learner/course/2854
Find out more »- ONLINE ON-DEMAND
Itching for a CSU Cure: The Shift From Symptom Relief to Curative Therapies – An Older African American Adult Male With Widespread, Persistent Pruritus
Join Chesahna Kindred, MD, MBA, FAAD, and Jonathan A. Bernstein, MD, as they discuss missed opportunities for the management and assessment of chronic spontaneous urticaria (CSU) in this interactive learning experience that uniquely mirrors what you may encounter in clinical practice. The activity will present you with a CSU patient with skin of color and challenge your clinical decision-making skills. https://realcme.realcme.com/learner/course/2855
Find out more »- ONLINE ON-DEMAND
Key Developments in Alzheimer’s Disease: Expert Insights on CTAD and ANA 2021 Annual Meetings
Looking for an expert-guided roundup of the 14th Clinical Trials on Alzheimer’s Disease (CTAD) and the American Neurological Association (ANA) annual meetings? Dr. Zoe Arvanitakis and Dr. Marwan Sabbagh offer their insights on key findings in the assessment and management of patients with Alzheimer’s disease (AD). Dive into this highly interactive educational activity and access our resource library stocked with video summaries and peer-reviewed articles to get up-to-date on recent advances in novel biomarkers for identifying early signs of AD and…
Find out more »January 2022
- ONLINE ON-DEMAND
Optimizing Outcomes in Newly Diagnosed Multiple Myeloma: Integrating Anti-CD38 Monoclonal Antibody Therapy Into Clinical Practice
Did you miss the latest updates on multiple myeloma presented at ASH 2021? Join Dr Faith Davies and Dr Nina Shah as they review late-breaking data on approved and emerging therapies for newly diagnosed multiple myeloma! https://learning.freecme.com/a/38663PA6uG2J
Find out more »- ONLINE ON-DEMAND
Seeing Beyond the Symptoms: Early Diagnosis and Treatment of Dry Eye and Meibomian Gland Dysfunction
Dry eye disease is one of the most common ophthalmic complaints; it results from the activity of various pathways and is considered a multifactorial disease. An important factor that contributes to the onset of dry eye disease is meibomian gland dysfunction. Meibomian gland dysfunction causes a disruption in the tear film lipid layer, which affects the rate of tear evaporation. This evaporation leads to tear hyperosmolarity, eventually triggering the onset of dry eye disease. Dry eye disease and meibomian gland…
Find out more »- ONLINE ON-DEMAND
Not Just Controlling the Itch: Recent Developments in Treating Prurigo Nodularis – A Caucasian Adult Male With History of Uncontrolled PN and Associated Comorbidities
Join our expert faculty, Chesahna Kindred, MD, MBA, FAAD and Shawn Kwatra, MD, FAAD, as they discuss patient scenarios utilizing methods to avoid missed opportunities for the care team, assess the clinical efficacy and safety of standard off-label, as well as emerging therapies, and ultimately devise effective treatment plans that encourage long-term adherence and address residual disease burden for patients with PN. Click the link below to access the course: https://realcme.realcme.com/learner/course/2866
Find out more »- ONLINE ON-DEMAND
Not Just Controlling the Itch: Recent Developments in Treating Prurigo Nodularis – An Older African American Female Adult Presenting With Nodular Lesions and Persistent Itching
Join our expert faculty, Chesahna Kindred, MD, MBA, FAAD and Shawn Kwatra, MD, FAAD, as they discuss patient scenarios utilizing methods to avoid missed opportunities for the care team, assess the clinical efficacy and safety of standard off-label, as well as emerging therapies, and ultimately devise effective treatment plans that encourage long-term adherence and address residual disease burden for patients with PN. Click the link below to access the course: https://realcme.realcme.com/learner/course/2865
Find out more »February 2022
- ONLINE ON-DEMAND
From Reversing DOACs to Restarting Anticoagulation: Know and Apply the Guidelines
When and how to use specific direct oral anticoagulant (DOAC) reversal agents is not straightforward. Two major professional societies (eg, the American College of Cardiology and the American College of Emergency Physicians ) issued expert panel recommendations for anticoagulant reversal only within the last year. In addition, reports of real-world experience with prothrombin complex concentrates (PCCSs) for DOAC reversal have been published in the recent past, potentially prompted by familiarity with PCCSs to reverse warfarin among other factors. Furthermore, evaluating…
Find out more »March 2022
- ONLINE ON-DEMAND
Incorporating New Therapeutic Tools for Migraine Prevention: An Expert-Guided Discussion
Looking for guidance on who may benefit from calcitonin gene-related peptide (CGRP)-targeted therapies for migraine prevention? Unsure which migraine preventive therapy may be best for your patient? In this CliniClip activity, Drs Jessica Ailani and Susan Hutchinson use real-world patient scenarios to share their expert insights on who may benefit from a CGRP-targeted therapy and highlight when a small molecule or a monoclonal antibody may be appropriate for migraine prevention. Click the link below to access the course: https://cmepreview.healio.com/neurology/20220207/incorporating-new-therapeutic-tools-for-migraine-prevention-an-expert-guided-discussion/cme-overview …
Find out more »- ONLINE ON-DEMAND
Women and Fabry Disease: What We Know, Why It Matters, and What Needs to Be Done
How does Fabry disease (FD) differ among women and men? Experts Dawn Laney, MS, CGC, CCRC, and Damara Ortiz, MD, FAAP, FACMG, discuss important clinical considerations for women with this lysosomal storage disorder in this 60-minute interactive live webcast. Gender-specific differences in the clinical presentation and diagnostic work-up for FD, current and emerging therapies in the management of FD, and the importance of elevating women in FD research are key points addressed in this activity. Mollie, an adult patient living…
Find out more »April 2022
- ONLINE ON-DEMAND
Dry Eye Disease and Meibomian Gland Dysfunction: Early Diagnosis and Comprehensive Management
Are you aware of the strong association between dry eye disease (DED) and meibomian gland dysfunction (MGD)? In this 30-minute educational podcast, Dr Eric D. Donnenfeld offers valuable insights on the association of DED and MGD, as well as the evidence-based protocol for clear and accurate diagnosis, and proper disease management, considering new and emerging therapies for DED and MGD.
Find out more »May 2022
- ONLINE ON-DEMAND
More Than Just Blood in the Urine: Recognizing and Treating IgA Nephropathy
Looking for the latest evidence from care guidelines and clinical trials in the management of immunoglobulin A nephropathy (IgAN)? Unsure which of the new and merging therapies may be best to consider for your patient with IgAN? In this E-monograph activity, Dr Mohamed Atta will review the important role of proteinuria in IgAN, and the impact of new and emerging therapies for IgAN to optimize proteinuria lowering in clinical practice and improve patient outcomes.
Find out more »